![Lei Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lei Chen
Directeur/Membre du Conseil chez SHANGHAI XFH TECHNOLOGY CO., LTD
Postes actifs de Lei Chen
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHANGHAI XFH TECHNOLOGY CO., LTD | Directeur/Membre du Conseil | 20/01/2016 | - |
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Lei Chen
Formation de Lei Chen
Tsinghua University | Graduate Degree |
Statistiques
Internationale
Chine | 4 |
Opérationnelle
Director/Board Member | 2 |
Graduate Degree | 1 |
Sectorielle
Producer Manufacturing | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
SHANGHAI XFH TECHNOLOGY CO., LTD | Producer Manufacturing |
Entreprise privées | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |